United States · FDA National Drug Code directory
Ezetimibe and Simvastatin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-838_0d4244dd-a226-4677-a6b2-6a1b5cd88790
- Product NDC
- 59651-838
- Form
- TABLET
- Composition / generic term
- Ezetimibe and Simvastatin
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240301
- Source listing expiry
- 20261231
Source-listed ingredients
- EZETIMIBE — 10 mg/1
- SIMVASTATIN — 80 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (59651-838-30) · 59651-838-30
- 90 TABLET in 1 BOTTLE (59651-838-90) · 59651-838-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →